Champions Oncology, Inc.CSBRNASDAQ
Loading
Year-over-year book value per share growth
| Period | Value |
|---|---|
| Q1 2026 | 2.77% |
| Q4 2025 | 19.56% |
| Q3 2025 | -6.44% |
| Q2 2025 | -31.29% |
| Q1 2025 | 696.82% |
| Q4 2024 | 305.12% |
| Q3 2024 | 82.55% |
| Q2 2024 | 7.53% |
| Q1 2024 | -2297.16% |
| Q4 2023 | -95.11% |
| Q3 2023 | -58.84% |
| Q2 2023 | -34.34% |
| Q1 2023 | -23.10% |
| Q4 2022 | 2.06% |
| Q3 2022 | -3.04% |
| Q2 2022 | 0.15% |
| Q1 2022 | 13.82% |
| Q4 2021 | 6.86% |
| Q3 2021 | 1.48% |
| Q2 2021 | -5.79% |
| Q1 2021 | 11.51% |
| Q4 2020 | 21.81% |
| Q3 2020 | 0.56% |
| Q2 2020 | 59.34% |
| Q1 2020 | 48.58% |
| Q4 2019 | 22.34% |
| Q3 2019 | -22.82% |
| Q2 2019 | -4.55% |
| Q1 2019 | 16.28% |
| Q4 2018 | 218.01% |
| Q3 2018 | 2502.59% |
| Q2 2018 | -105.30% |
| Q1 2018 | 26.74% |
| Q4 2017 | 28.20% |
| Q3 2017 | -27.50% |
| Q2 2017 | -80.42% |
| Q1 2017 | -36.35% |
| Q4 2016 | 0.91% |
| Q3 2016 | 943.96% |
| Q2 2016 | -89.31% |